News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Roche Holding AG Seeks to Broaden Use of Cancer Drug MabThera
March 22, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Swiss drugmaker Roche Holding AG (ROG.VX) is looking to broaden the use of its cancer drug MabThera in non-Hodgkin's lymphoma in Europe, underscoring the strength of its position in oncology.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
Europe
MORE ON THIS TOPIC
Tariffs
Trump Carves Tariff Exemptions for Some Pharma Products
September 12, 2025
·
2 min read
·
Tristan Manalac
China
Trump Reportedly Preparing Order Restricting Chinese Drug Licensing Deals
September 11, 2025
·
2 min read
·
Dan Samorodnitsky
Pain
FDA Looks To Streamline Development of Non-Opioid Painkillers
September 11, 2025
·
2 min read
·
Tristan Manalac
CDC
Ousted CDC Director Monarez to Testify In Front of Senate After RFK Jr. Clash
September 10, 2025
·
2 min read
·
Tristan Manalac